文献速递细菌感染、耐药与抗菌药物医院感染防控

三级医院多重耐药弗氏柠檬酸杆菌复合群流行病学与分子监测

Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究在日内瓦大学医院对2017至2022年收集的产超广谱β-内酰胺酶和碳青霉烯酶的弗氏柠檬酸杆菌复合群进行回顾性基因组与流行病学研究。共识别103例,其中79%为医院获得性,72%来自直肠拭子,6例发生菌血症。全基因组测序显示弗氏柠檬酸杆菌遗传多样性高,存在克隆传播和质粒介导传播。

要点

  • 弗氏柠檬酸杆菌复合群是医院感染中抗菌药物耐药克隆与质粒传播的载体。
  • 产ESBL和碳青霉烯酶的弗氏柠檬酸杆菌中79%为医院获得性,应纳入基因组监测以发现隐匿传播。
  • 腹外科、老年科和感染性骨科是推测传播事件的高发科室。

核心结论

  • 弗氏柠檬酸杆菌是克隆传播和质粒介导的医院内抗菌药物耐药传播的载体。
  • 有必要将弗氏柠檬酸杆菌纳入基因组与流行病学监测,以发现其隐匿传播。

研究设计与样本

  • 在日内瓦大学医院开展6年(2017-2022)回顾性基因组与流行病学研究。
  • 对产ESBL和碳青霉烯酶的弗氏柠檬酸杆菌复合群采用Nanopore长读长全基因组测序、MLST、质粒分型和耐药组分析。
  • 传播事件依据遗传相关性、质粒相似性和患者轨迹定义。

主要发现

  • 共识别103例产ESBL和碳青霉烯酶的弗氏柠檬酸杆菌复合群病例,79%为医院获得性,72%分离自直肠拭子,6例发生菌血症。
  • 90株可测序分离株中73%确认为弗氏柠檬酸杆菌,其余为其他柠檬酸杆菌菌种。
  • 弗氏柠檬酸杆菌狭义种内高度遗传多样,共29个序列型,以ST114、ST98和ST22为主。
  • 35例患者中识别10个涉及多种柠檬酸杆菌的聚集,中位聚集持续时间为103周(IQR,65-138)。
  • 37%患者涉及推测克隆传播,21%涉及推测质粒介导传播,常涉及携带blaCTX-M-15、blaOXA-48/CTX-M-14b和blaOXA-181的IncHI2-IncHI2A、IncM1和IncX3质粒。

关键数值与推荐

  • 共103例产ESBL和碳青霉烯酶的弗氏柠檬酸杆菌复合群病例,79%为医院获得性,72%分离自直肠拭子,6例发生菌血症。
  • 90株可测序分离株中73%确认为弗氏柠檬酸杆菌,其余为其他柠檬酸杆菌菌种。
  • 弗氏柠檬酸杆菌狭义种共29个序列型,以ST114、ST98和ST22为主。
  • 35例患者中识别10个涉及多种柠檬酸杆菌的聚集,中位聚集持续时间为103周(IQR,65-138)。
  • 37%患者涉及推测克隆传播,21%涉及推测质粒介导传播。

临床怎么用

  • 对产ESBL和碳青霉烯酶的弗氏柠檬酸杆菌应结合基因组监测识别医院内克隆与质粒传播。
  • 关注腹外科、老年科和感染性骨科等科室的潜在传播,并重视直肠拭子筛查。
  • 监测应覆盖弗氏柠檬酸杆菌复合群中多种柠檬酸杆菌菌种,而非仅弗氏柠檬酸杆菌狭义种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Citrobacter freundii is an emerging nosocomial pathogen, yet its transmission dynamics remain poorly characterized. METHODS: We conducted a retrospective genomic and epidemiological study to investigate the transmission chains of extended-spectrum beta-lactamase (ESBL) and carbapenemase-producing C. freundii collected at Geneva University Hospitals during a 6-year period (2017-2022). Whole-genome sequencing (WGS) using Nanopore long-read sequencing, MLST and plasmid typing, and resistome profiling were performed. Transmission events were defined based on genetic relatedness, plasmid similarity and patient trajectories. RESULTS: A total of 103 cases of ESBL and carbapenemase-producing C. freundii were identified, of which 79% were hospital-acquired, 72% were isolated from rectal swabs, and bacteremia occurred in 6 patients. Among 90 isolates available for WGS, 73% were confirmed as C. freundii, whereas the remaining belonged to other Citrobacter species. A high genetic diversity was observed among C. freundii sensu stricto, with 29 distinct sequence types, including predominant ST114, ST98, and ST22. We identified 10 clusters involving multiple Citrobacter species among 35 patients, with a median cluster duration of 103 weeks (IQR, 65-138). Transmission chain analysis revealed that 37% of patients were involved in putative clonal transmission and 21% in putative plasmid-mediated dissemination events, particularly in abdominal surgery, geriatrics and septic orthopedics, often involving C. freundii harboring blaCTX-M-15, blaOXA-48/CTX-M-14b, and blaOXA-181 on IncHI2-IncHI2A, IncM1, and IncX3 plasmids, respectively. CONCLUSIONS: Our study highlights the role of C. freundii as a vector of both clonal and plasmid-mediated, nosocomial transmission of antimicrobial resistance. It emphasizes the need to include C. freundii in genomic and epidemiological surveillance to detect its silent spread.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Fonton P, Sierra R, Martischang R, et al. Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study. J Infect Dis. 2026. PMID: 41635259. doi:10.1093/infdis/jiag066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。